Literature DB >> 25023120

Novel bacterial ADP-ribosylating toxins: structure and function.

Nathan C Simon1, Klaus Aktories2, Joseph T Barbieri1.   

Abstract

Bacterial ADP-ribosyltransferase toxins (bARTTs) transfer ADP-ribose to eukaryotic proteins to promote bacterial pathogenesis. In this Review, we use prototype bARTTs, such as diphtheria toxin and pertussis toxin, as references for the characterization of several new bARTTs from human, insect and plant pathogens, which were recently identified by bioinformatic analyses. Several of these toxins, including cholix toxin (ChxA) from Vibrio cholerae, SpyA from Streptococcus pyogenes, HopU1 from Pseudomonas syringae and the Tcc toxins from Photorhabdus luminescens, ADP-ribosylate novel substrates and have unique organizations, which distinguish them from the reference toxins. The characterization of these toxins increases our appreciation of the range of structural and functional properties that are possessed by bARTTs and their roles in bacterial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023120      PMCID: PMC5846498          DOI: 10.1038/nrmicro3310

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  196 in total

1.  Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation.

Authors:  D A Bobak; M M Bliziotes; M Noda; S C Tsai; R Adamik; J Moss
Journal:  Biochemistry       Date:  1990-01-30       Impact factor: 3.162

2.  Aeromonas salmonicida toxin AexT has a Rho family GTPase-activating protein domain.

Authors:  Yael Litvak; Zvi Selinger
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

3.  Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

Authors:  A Ruf; J Mennissier de Murcia; G de Murcia; G E Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.

Authors:  S Han; J A Craig; C D Putnam; N B Carozzi; J A Tainer
Journal:  Nat Struct Biol       Date:  1999-10

5.  Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum.

Authors:  E J Rubin; D M Gill; P Boquet; M R Popoff
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Identification of SpyA, a novel ADP-ribosyltransferase of Streptococcus pyogenes.

Authors:  Lisette H Coye; Carleen M Collins
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

7.  Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor.

Authors:  G V Louie; W Yang; M E Bowman; S Choe
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

8.  Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177.

Authors:  J Vandekerckhove; B Schering; M Bärmann; K Aktories
Journal:  FEBS Lett       Date:  1987-12-10       Impact factor: 4.124

Review 9.  Membrane traffic and the cellular uptake of cholera toxin.

Authors:  W I Lencer; T R Hirst; R K Holmes
Journal:  Biochim Biophys Acta       Date:  1999-07-08

10.  The three-dimensional crystal structure of cholera toxin.

Authors:  R G Zhang; D L Scott; M L Westbrook; S Nance; B D Spangler; G G Shipley; E M Westbrook
Journal:  J Mol Biol       Date:  1995-08-25       Impact factor: 5.469

View more
  81 in total

1.  Defective heart chamber growth and myofibrillogenesis after knockout of adprhl1 gene function by targeted disruption of the ancestral catalytic active site.

Authors:  Stuart J Smith; Norma Towers; Kim Demetriou; Timothy J Mohun
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

2.  Substrate N2 atom recognition mechanism in pierisin family DNA-targeting, guanine-specific ADP-ribosyltransferase ScARP.

Authors:  Toru Yoshida; Hideaki Tsuge
Journal:  J Biol Chem       Date:  2018-08-02       Impact factor: 5.157

Review 3.  Enterotoxigenic Escherichia coli Infections.

Authors:  James M Fleckenstein; F Matthew Kuhlmann
Journal:  Curr Infect Dis Rep       Date:  2019-03-04       Impact factor: 3.725

4.  Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies.

Authors:  Bronwyn Lyons; Ravikiran Ravulapalli; Jason Lanoue; Miguel R Lugo; Debajyoti Dutta; Stephanie Carlin; A Rod Merrill
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

Review 5.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

Review 6.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

7.  The NarE protein of Neisseria gonorrhoeae catalyzes ADP-ribosylation of several ADP-ribose acceptors despite an N-terminal deletion.

Authors:  Paula I Rodas; A Said Álamos-Musre; Francisca P Álvarez; Alejandro Escobar; Cecilia V Tapia; Eduardo Osorio; Carolina Otero; Iván L Calderón; Juan A Fuentes; Fernando Gil; Daniel Paredes-Sabja; Myron Christodoulides
Journal:  FEMS Microbiol Lett       Date:  2016-07-26       Impact factor: 2.742

8.  The roles of AtxA orthologs in virulence of anthrax-like Bacillus cereus G9241.

Authors:  Jennifer M Scarff; Malik J Raynor; Yuliya I Seldina; Christy L Ventura; Theresa M Koehler; Alison D O'Brien
Journal:  Mol Microbiol       Date:  2016-09-04       Impact factor: 3.501

9.  When Escherichia coli doesn't fit the mold: A pertussis-like toxin with altered specificity.

Authors:  Chen Chen; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2017-09-08       Impact factor: 5.157

10.  Cell-penetrating peptides derived from Clostridium difficile TcdB2 and a related large clostridial toxin.

Authors:  Jason L Larabee; Garrett D Hauck; Jimmy D Ballard
Journal:  J Biol Chem       Date:  2017-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.